-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Maintains Buy on Aspen Aerogels, Lowers Price Target to $3

Benzinga·02/26/2026 17:42:55
Listen to the news
Roth Capital analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $6 to $3.